Skip to main content
Royal Society Open Science logoLink to Royal Society Open Science
. 2019 Jun 19;6(6):181963. doi: 10.1098/rsos.181963

Sustainable and scalable synthesis of polysubstituted bis-1,2,4-triazoles, bis-2-iminothiazolines and bis-thiobarbiturates using bis-N,N-disubstituted thioureas as versatile substrate

Wael Abdelgayed Ahmed Arafa 1,2,, Hamada Mohamed Ibrahim 2
PMCID: PMC6599792  PMID: 31312476

Abstract

An expedient and tandem regioselective one-pot protocol for the sono-synthesis of bis-[1,2,4]-triazol-3-yl amines and bis-2-iminothiazolines from corresponding bis-1,3-disubstituted thioureas has been developed. The products' regioselectivity correlate well with the pKas of the parent amines, in which the amine possessing higher pKa goes to the ring nitrogen, whereas the other nitrogen remains flanked as an exocyclic nitrogen of the bis-triazole or bis-thiazole moieties. Further, the sonochemical preparation of both bis-5-(2-nitrobenzylidene) thiobarbiturates and bis-2-thioxoimidazolidine-4,5-diones from bis-1,3-disubstituted thioureas has also been achieved. The obtained bis-5-(2-nitrobenzylidene)thiobarbiturates easily underwent reductive cyclization to afford the corresponding bis-5-benzo[c]isoxazol-3-ylidenethiobarbiturates. The scope and limitations of these strategies have been studied. Moreover, the suggested methodologies have advantages such as broad functional group tolerance, mild conditions, operational simplicity and applicability on a gram scale. Furthermore, the protocols scored well in a number of green metrics, subsequently showing these approaches to be environmentally benign and sustainable processes.

Keywords: regioselectivity; ultrasonic irradiation; bis-[1,2,4]-triazol-3-yl amines; bis-2-iminothiazolines; green metrics

1. Introduction

As of late, organic chemists have given careful consideration to heterocyclic compounds in light of their potential significance in the agricultural and pharmaceutical fields. 1,2,4-Triazole and bis-1,2,4-triazole derivatives have been well reported to show wide potential applications in chemical, medicinal, supramolecular, agricultural and also in materials sciences [16]. Furthermore, a considerable number of triazole-based medicines have been broadly used in clinic, for example, Letrozole [2], Voriconazole [7] and Anastrozole [8], which have been used as non-steroidal aromatase inhibitors in drugs for breast cancer treatment. In spite of the numerous protocols reported in the literature for the preparation of [1,2,4]-triazoles having diversified substituents, few of these mention the preparation of the triazole possessing no substitution at position 5 [6]. Furthermore, most of these methods suffer from serious ecological concerns as they comprise the utilization of strong acidic or basic conditions, expensive and poisonous chemicals, thereby impeding the application of these protocols. Hence, development of more sustainable methodology for the assembly of bis-[1,2,4]-triazoles is therefore of great significance. Thiazoles and their bis-heterocycles stand out among the most important moieties in drug design and heterocyclic chemistry. Thiazole motif is broadly found in some naturally occurring substances and varied pharmaceutically active compounds [913]. As well, thiobarbituric acids (TBA) and their 5-arylidine derivatives have turned out to be attractive to medicinal chemists because of their broad scope of biological activities and as intermediates in the preparation of heterocyclic compounds [1419]. Also, thiobarbiturates are broadly used for the synthesis of diverse complexes [20,21], being employed as a reagent for spectrophotometric investigation of numerous metals [2023], to determine the oxidation degree of natural fats in nutrients [2426] and industrially as thermal stabilizers for rigid poly(vinyl chloride) at high temperature [27]. Imidazole motif exists widely in different types of naturally occurring and synthetic pharmaceutical compounds and displays assortment of pharmacological activities [2830]. Moreover, imidazole derivatives are used as building blocks in natural product synthesis [31], catalysis [32] and coordination chemistry [33]. In the novel effective and facile synthetic protocols of heterocycles, the merits of a strategy are measured by speed, inexpensive starting materials and energy sources. In this regard, utilization of sonochemistry as attractive methodologies to realize these aims has been recently reported [34]. Small cavities that generated as a result of ultrasonic waves travel through the liquid and lead to chemical reactions. This cavitation leads to the creation of micro-bubbles in the liquid, which on imploding generate high temperatures and pressures in their surroundings [35]. In comparison with traditional procedures, decreased reaction times, improved yields and diminished energy used are significant merits of ultrasound methodology. As a part of our ongoing research plan on the preparation of diversified biologically active bis-heterocyclic compounds and on interesting new and eco-friendly green synthetic protocols [3641], a straightforward synthetic procedure for the synthesis of novel series of bis-heterocycles can be effectively accomplished under ultrasound irradiation as a viable greener technique. Furthermore, the electronic impact of the 1,3-substituents on the bis-thiourea performs an essential role on the regioselectivity of the cyclization and product distribution.

2. Results and discussion

The genesis of this work has commenced with one of our recent papers on a green synthetic procedure for the synthesis of asymmetrically substituted bis-thioureas (scheme 1) [39]. The bis-thioureas (3ad) were obtained in excellent yields by the reaction of isothiocyanates (1a, b) with diamines (2a, b) in CH3CN by using ultrasound irradiation as a sustainable energy source (scheme 1).

Scheme 1.

Scheme 1.

An ultrasound-assisted methodology for the preparation of unsymmetrically substituted bis-thioureas 3a–d [39].

Firstly, we thought of developing an eco-friendly one-pot protocol for the assembly of bis-3-amino-[1,2,4]-triazoles. Our aim was to select chemicals and optimize different reaction conditions to find a general protocol that can be used to synthesize regioselective bis-[1,2,4]-triazol-3-yl amines via oxidative desulfurization reaction. The feasibility of our envisioned protocol can be tested by conducting the following model reaction: to a solution of bis-thiourea 3a (1.0 equiv) in ethanol (10 ml) were added 2.0 equiv of formic hydrazide and 2.0 equiv of HgCl2 portion-wise over a time of 5 min at ambient temperature (25°C). Generation of a novel product alongside other little side products was observed together with the retention of some starting materials. Purification and characterization by usual methods revealed the product to be hitherto unreported 4,4'-[(1R,4R)-cyclohexane-1,4-diyl)bis(N-benzyl-4H-1,2,4-triazol-3-amine] (4a) (17% isolated yield, table 1, entry 1). Our next target was to identify an appropriate thiophile to accomplish this reaction. We selected to compare two mercury(II) salts (table 1, entries 1 and 2) and the I2/K2CO3 reagent (table 1, entry 3) as thiophile and checked the generation of 4a by thin layer chromatography (TLC) in the model reaction.

Table 1.

Optimization of reaction conditions for preparation of 4a.

graphic file with name rsos181963-i1.jpg

entry thiophile method thiophile molar ratio time (min) yield (%)
1 HgCl2 stirring 2.0 60 17
2 Hg(OAc)2 stirring 2.0 60 22
3 I2/K2CO3 stirring 2.0 60 67
4 I2/K2CO3 US 2.0 15 90
5 I2/K2CO3 US 2.0 10 86
6 I2/K2CO3 US 2.0 20 90
7 I2/K2CO3 US 2.0 40 90
8 I2/K2CO3 US 3.0 15 96
9 I2/K2CO3 US 4.0 15 96

According to the yields of the product (table 1, entries 1–3), it was obvious that I2/K2CO3 was the optimal thiophile for this model reaction, and henceforth we chose to use I2/K2CO3 for all next reactions as the thiophile. Interestingly, when the aforesaid model reaction was conducted under ultrasound (US) irradiation, the required derivative (4a) acquired in good yield (90%) and in short reaction time (table 1, entry 4). Screening of some other inorganic salts, for example, KHCO3, Na2CO3, NaHCO3 and Cs2CO3 were also found to be evenly efficacious. In a further reaction, it was also observed that shorter periods of sonication afforded diminished yields (table 1, entry 5), whereas longer periods gave no advantage (table 1, entries 6 and 7). By varying the amount of thiophile in the above reaction (table 1, entries 8 and 9), it was found that 3.0 equiv of I2/K2CO3 provided the best yield of 4a in 96% (table 1, entry 8). Finally, the optimized conditions for this desulfurization reaction involved sonication of 1.0 equiv of 3a and 2.0 equiv of NH2NHCHO with 3.0 equiv of I2/K2CO3 in ethanol (10 ml) for 15 min at ambient temperature which offered an excellent 96% yield of 4a (table 1, entry 8). Because our target is to develop a more environmentally friendly methodology, non-environmental organic bases and solvents have not been studied for this conversion.

Since the formation of bis-[1,2,4]triazole (4a) is an addition-dehydration reaction, we postulated that the substituents linked to the thiourea nitrogens would perform an essential role in the ring closure regioselectivity. To investigate the impact of substituent on the construction of the bis-[1,2,4]triazoles, a series of asymmetrical bis-thioureas (3ad) were studied. A one-pot reaction was accomplished with the bis-thioureas (3ad), I2, K2CO3, and NH2NHCHO (1:3:3:2 equiv) blended together at ambient temperature with sonication for 15 min. The outcomes are outlined in table 2.

Table 2.

Substrate scope for bis-[1,2,4]triazoles 4 and 5.

graphic file with name rsos181963-i2.jpg

entry R R′ yield (%)
4 5
1 C6H5 cyclohexyl 93 (4a) 0
2 CH=CH2 cyclohexyl 90 (4b) 0
3 C6H5 –CH2–C6H4–CH2 57 (4c) 43 (5a)
4 CH=CH2 –CH2–C6H4–CH2 50 (4d) 50 (5b)

From the results outlined in table 2, a good correlation between pKa of the parent amines and product regioselectivity could be set up. According to the suggested mechanism in scheme 2, the intermediate (I), that formed under the influence of catalyst, underwent desulfurization reaction to afford intermediate (II). Then, the formic hydrazide attacked the in situ produced unsymmetrical bis-carbodiimide (II) followed by protonation at the nitrogen having higher pKa (scheme 2) to afford intermediate (III) instead of at the nitrogen having lower pKa. After that, intermediate (III) underwent an intramolecular nucleophilic attack from nitrogen lone pair onto the aldehydic carbonyl group to give structure (IV). Finally, intermediate (IV) underwent a dehydration step to furnish the regioisomeric bis-[1,2,4]-triazole derivative 4a. Therefore, the nitrogen atom of amine linked to the thiourea possessing lower pKa stays as exocyclic nitrogen in the final product, whereas the other nitrogen atom (having higher pKa) would be involved in the ring. Also, this has been confirmed during our regioselective preparation of thiazole-2-imines [39]. Accordingly, it is anticipated that large difference in values of pKa of amines linked to bis-thiourea should afford solely one regioisomer, whereas small difference should give two regioisomers. For example, under the optimized reaction condition, the asymmetrical bis-thiourea 3c comprising both benzyl amine (pKa = 9.34) and p-xylylene diamine (pKa = 9.46) provided a mixture of both regioisomers 4c and 5a in the ratio of 57 : 43 (table 2, entry 3). Also, in the case of using the unsymmetrical bis-thiourea 3d containing allyl amine (pKa = 9.49) and p-xylylene diamine (pKa = 9.46), both regioisomers 4d and 5b were obtained in the ratio of 50 : 50 (table 2, entry 4). Whereas, other thioureas (3a, b) possessing a pKa difference of 1.46 and 1.34 units, respectively, affording only one regioisomer (4a and 4b, respectively; table 2, entries 1 and 2). Notwithstanding the isolation of water during the reaction (scheme 2), no traces of urea (as a result of water attack to carbodiimide intermediate (II)) were detected; probably attributable to the more nucleophilic nature of the formic acid hydrazide compared with water.

Scheme 2.

Scheme 2.

A postulated mechanism for the preparation of bis-[1,2,4]triazoles 4a.

The conventional preparation of thiazoles includes the Hantzsch condensation reaction of α-haloketones and thioureas, which affords after dehydrohalogenation the 2-iminothiazoles [42]. In the reinvestigation of the synthesis of thiazoles using Hantzsch methods under sonication, six new bis-2-iminothiazolines 79 were acquired in excellent yields. Thus, reaction of bis-thioureas 3ad with o-methoxy phenacyl bromide (6) was carried out using catalytic amount of sodium acetate and sonication at 80°C for 10 min to give bis-2-iminothiazolines 79 (scheme 3). Unsymmetrical thioureas 3a, b (with higher pKa differences) smoothly underwent the reaction to give the sole regioisomeric products 7a, b in a slightly preferable yield than those 3c, d (with lesser pKa differences) which afforded a mixture of regioisomeric products 8 and 9 (scheme 3).

Scheme 3.

Scheme 3.

An ultrasound-assisted methodology for the preparation of bis-iminothiazoles 79.

Thereafter, on heating (60°C) of derivatives 3ad (1 mmol) with malonic acid (2.2 mmol) in acetyl chloride (6.0 mmol) or oxaloyl chloride (2.2 mmol) afforded the hitherto unreported bis-thiobarbituric acids (10ad) and bis-imidazoles (11ad), respectively, with inadmissible results (scheme 4). Consequently, some reaction variables, for instance, reagents stoichiometry, energy sources and times, were investigated using bis-thiourea 3a as the model substrate for improving reaction yield. Optimization resulted in 1.0 equiv of 3a, 2.2 equiv of oxaloyl chloride or 2.2 equiv malonic acid (in 6.0 equiv of acetyl chloride) under sonication at 40°C for 7 min, affording derivatives 10a and 11a in 99% and 96%, respectively. After establishing an effective protocol for these reactions, a diversified range of bis-thioureas (3a–d) were employed to synthesize functionalized bis-thiobarbituric acids (10ad) and bis-imidazoles (11ad). It was noticed that the electronic nature of bis-thioureas had a minor impact on the reaction effectiveness, afforded the corresponding products in excellent yields. Different from derivatives 3a–d, FT-IR and 13C NMR spectra of derivatives 10 and 11 exhibited additional signals originated from carbonyl functions at the related regions. Furthermore, in the 1H NMR spectra of derivatives 10 and 11, no signals were recorded corresponding to the NH groups (thiourea moiety).

Scheme 4.

Scheme 4.

An ultrasound-assisted methodology for the preparation of 10 and 11.

2,1-Benzisoxazole (anthranil) is a privileged heterocycle that is used for the synthesis of biologically active derivatives such as acridines and quinolones [43,44]. To best of our knowledge, bis-2,1-benzisoxazoles possessing exo-double bonds at 5-position have not been reported. We herein present the first synthesis of bis-2,1-benzisoxazoles (13ad) from bis-thiobarbituric acids (10ad). In a prototypical reaction, to a solution of bis-thiobarbituric acids (10ad) (1.0 mmol) in water (10 ml), was added o-nitrobenzaldehyde (2.1 mmol) and the obtained mixture was sonicated (40 MHz) at 80°C for 5 min, which afforded the desired products (12ad) in excellent yields (scheme 5). Then, the preparation of bis-2,1-benzisoxazoles (13a–d) was accomplished from the reduction of derivatives (12ad) with SnCl2.2H2O/HCl in ethanol under sonication for 10 min at 80°C (scheme 5).

Scheme 5.

Scheme 5.

An ultrasound-assisted methodology for the preparation of 13ad.

Interestingly, compounds 13ad could be also synthesized via one-pot consecutive reaction. After sonication of the solution of bis-thiobarbituric acids (10ad) (1.0 mmol) and o-nitrobenzaldehyde (2.0 mmol) in water (10 ml) for 5 min, water was removed under vacuum and the remaining residue was suspended in ethanol, to which, SnCl2.2H2O/HCl were added. The resulting mixture was then sonicated for 10 min at 80°C. The mechanism of this reaction presumably involves generation of the non-separable bis-nitrosoarene intermediate (VI), via a partial reduction of the nitro groups, which would subsequently act as a nucleophile able to attack the bis-thiobarbiturate in a typical Michael addition reaction to yield the desired products 13a–d (scheme 5). The suggested structures (scheme 5) were approved by spectral analyses. In the 1H NMR spectra of derivatives 13ad, two doublets were observed in the ranges of 7.98–7.80 and 6.80–6.78 ppm attributed to the o-substituted benzene ring. Also, in the 13C NMR spectra, the signals at about 179, 161 and 86 ppm were specified to C=S, C=O and methylenic carbon, respectively.

The enhancement in the rate and yield of these sonochemical reactions may be attributed to the acoustic cavitation [45], in which the vapour bubbles that form in low-pressure regions collapse when subjected to higher pressure, with the implosion generating extremely high localized temperatures more than 5000 K and high pressures more than 1000 atm [46]. Collapsing bubbles filled with diaromatic vapour produce localized points of extremely high temperature ‘hotspot’ that are sufficient to drive the reactions within short time in high yields [47].

In order to demonstrate the potential for scale-up of the aforementioned protocols, we performed representative reactions on the gram scale and the isolated desired products are summarized in table 3. Some green metrices [48] such as E-factor (EF), process mass intensity (PMI), atom economy (AE), carbon efficiency (CE), reaction mass efficiency (RME) and yield economy (YE) were calculated for these processes and the results are tabulated in table 3. The higher environmental compatibility green metrics such as smaller values of EF and higher values of PMI, AE, CE, RME and YE confirm the environmental friendliness of the current protocols.

Table 3.

Calculated green metrics for the scaled-up preparation of compounds 4a, 7a, 10a, 13a.

entry derivative yield
EF PMI AE(%) CE(%) RME(%) YE(%)
g %
1 4a 4.2 98 0.019 1.3 91 100 79 6.5
2 7a 6.5 96 0.038 1.3 78 100 74 9.6
3 10a 5.3 98 0.14 1.2 88 100 86 14
4 13a 7.6 97 0.03 1.1 92 100 89 6.5

3. Conclusion

In conclusion, straightforward and highly effective regioselective protocols for the sono-synthesis of bis-[1,2,4]-triazol-3-yl amines and bis-2-iminothiazolines from corresponding asymmetrically substituted bis-thioureas have been successfully demonstrated. The product regioselectivity correlated well with the pKas of the parent amines; the amine possessing higher pKa become part of the ring, while that having lower pKa remains as an exocyclic nitrogen in the final product. Therefore, the present protocol afforded an approach to the generation of one regioisomer through appropriate tuning of the pKas of the used amines. Furthermore, an efficient methodology to sono-synthesize bis-isoxazolthiobarbiturates and bis-imidazoles from bis-1,3-disubstituted thioureas has been also described. The reactions proceed smoothly affording target products in excellent yields. Moreover, an assortment of green metrics has been discussed and our protocol exemplary fit in this grid.

4. Experimental procedure

4.1. General information

NMR spectra were determined on Bruker Ultra Shield spectrometer at 400 (1H) and 100 (13C) MHz. Chemical shifts are recorded in parts per million (ppm) and are referenced to TMS. Analytical thin layer chromatography (TLC) was employed on a silica gel plate (Merck® 60F254). IR spectra were recorded on Perkin–Elmer Spectrum One spectrometer. Sonication was performed in a SY5200DH-T ultrasound cleaner. Melting points were measured on Electrothermal IA9100 melting point apparatus (UK). All chemicals were commercially available and were used without any purification.

4.2. Synthesis of bis-1,2,4-triazol-3-amine derivatives 45

To a solution of bis-thioureas 3a–d (1.0 mmol) in ethanol (10 ml) were added sequentially NH2NHCHO (2.0 mmol) and aqueous K2CO3 (3.0 mmol in 1 ml water) and the mixture was sonicated at ambient temperature (25°C). Then, I2 (3.0 mmol) was appended portion-wise within 5 min. After that, the reaction mixture was sonicated for a further 10 min (monitoring by TLC). During this period, the iodine colour vanished with the appearance of elemental sulfur. After filtration, the solvent was removed under reduced pressure and the remaining residue was treated with 5% sodium thiosulfate (5 ml). The reaction product was then purified over a column of silica gel and eluted with DCM/MeOH mixture to afford the corresponding compounds 4 and 5.

4.2.1. 4,4'-((1R,4R)-Cyclohexane-1,4-diyl)bis(N-benzyl-4H-1,2,4-triazol-3-amine) 4a

Yellow crystals, yield 96%, m.p. 296–298°C; IR (KBr): ν/cm−1 3328 (NH), 1610 (C=N); 1H NMR (400 MHz, DMSO-d6): δ 8.60 (s, 2H, triazole-H), 7.35–7.25 (m, 10H, Ar-H), 4.13 (s, 4H, CH2), 3.93 (br, 2H, cyclohexyl-H), 1.92–1.91 (m, 4H, cyclohexyl-H), 1.26–1.19 ppm (m, 4H, cyclohexyl-H); 13C NMR (100 MHz, DMSO-d6): δ 150.2 (triazole-C3), 142.4 (triazole-C5), 138.4, 129.9, 128.6, 127.6 (Ar-C), 51.4 (cyclohexyl-C), 47.7 (CH2), 30.3 ppm (cyclohexyl-C); MS (EI): m/z (%) 429 (M++1, 2.2), 428 (M+, 11.6), 337 (M+−91, 100).

4.2.2. 4,4'-((1R,4R)-Cyclohexane-1,4-diyl)bis(N-allyl-4H-1,2,4-triazol-3-amine) 4b

Yellow crystals, yield 95%, m.p. 285–286°C; IR (KBr): ν/cm−1 3310 (NH), 1625 (C=N); 1H NMR (400 MHz, DMSO-d6): δ 8.56 (s, 2H, triazole-H), 5.91–5.80 (m, 2H, –CH2–CH=CH2), 5.17–5.05 (m, 4H, –CH2–CH=CH2), 4.06 (br, 4H, –CH2–CH=CH2), 3.18–3.13 (br, 2H, cyclohexyl-H), 1.78–1.76 (m, 4H, cyclohexyl-H), 1.46–1.40 ppm (m, 4H, cyclohexyl-H); 13C NMR (100 MHz, DMSO-d6): δ 151.6 (triazole-C3), 142.9 (triazole-C5), 135.3 (–CH2CH=CH2), 115.7 (–CH2–CH=CH2), 51.8 (cyclohexyl-C), 45.9 (–CH2–CH=CH2), 30.7 ppm (cyclohexyl-C); MS (EI): m/z (%) 329 (M++1, 4.6), 328 (M+, 100).

4.2.3. 4,4'-(1,4-Phenylenebis(methylene))bis(N-benzyl-4H-1,2,4-triazol-3-amine) 4c and N,N'-(1,4-phenylenebis(methylene))bis(4-benzyl-4H-1,2,4-triazol-3-amine) 5a

The crude reaction mixture comprising both the non-isolable regioisomeric products was purified by column chromatography (96% DCM/MeOH) to afford the mixture of regioisomers 4c and 5a in the ratio of (57 : 43); Rf = 0.37. Yellow crystals, yield 96%, m.p. 256–259°C; IR (KBr): ν/cm−1 3329 (NH), 1609 (C=N); 1H NMR (400 MHz, DMSO-d6): δ 8.674 (s, 2H, triazole-H), 8.670 (s, 2H, triazole-H), 7.32–7.18 (m, Ar-H), 4.84–4.82 (m, CH2), 4.45–4.42 ppm (m, CH2); 13C NMR (100 MHz, DMSO-d6): δ 153.0 (triazole-C3), 152.6 (triazole-C3), 145.5 (triazole-C5), 145.3 (triazole-C5), 138.9, 138.6, 137.0, 129.5, 129.2, 128.8, 128.3, 128.1, 127.5, 127.1, 126.8, 126.5 (Ar-C), 47.6, 47.5, 45.8 ppm (CH2); MS (EI): m/z (%) 451 (M++1, 0.9), 450 (M+, 4.2), 359 (M+−91, 100).

4.2.4. 4,4'-(1,4-Phenylenebis(methylene))bis(N-allyl-4H-1,2,4-triazol-3-amine) 4d and N,N'-(1,4-phenylenebis(methylene))bis(4-allyl-4H-1,2,4-triazol-3-amine) 5b

The crude reaction mixture comprising both the non-isolable regioisomeric products was purified by column chromatography (98% DCM/MeOH) to give the mixture of regioisomers 4d and 5b in the ratio of (50 : 50); Rf = 0.41. Yellow crystals, yield 95%, m.p. 235–239°C; IR (KBr): ν/cm−1 3285 (NH), 1612 (C=N); 1H NMR (400 MHz, DMSO-d6): δ 8.607 (s, 2H, triazole-H), 8.600 (s, 2H, triazole-H), 7.34–7.27 (m, Ar-H), 5.88–5.79 (m, –CH2–CH=CH2), 5.62–5.60 (m, –CH2–CH=CH2), 5.17–4.97 (m, –CH2–CH=CH2), 4.75–4.69 (m, –CH2–CH=CH2), 4.26 (br, CH2), 4.03 ppm (s, CH2); 13C NMR (100 MHz, DMSO-d6): δ 152.3 (triazole-C3), 152.1 (triazole-C3), 145.3 (triazole-C5), 145.0 (triazole-C5), 137.4, 135.7, 134.3, 128.5, 128.2 (Ar-C), 135.6, 135.3 (–CH2CH=CH2), 115.8 (–CH2–CH=CH2), 45.7, 45.6 (–CH2–CH=CH2), 47.7, 47.5 ppm (CH2); MS (EI): m/z (%) 351 (M++1, 1.3), 350 (M+, 4.8), 309 (M+−41, 100).

4.3. Synthesis of bis-thiazol-2-imine 79

A mixture of bis-thioureas 3a-d (1.0 mmol), o-methoxy phenacyl bromide (6) (2.0 mmol, 454.0 mg) and NaOAc (2.0 mmol) were sonicated in ethanol (20 ml) for 10 min at 80°C. The reaction was controlled by TLC and continued until the starting materials completely disappeared, then left to cool to room temperature. The formed solid was filtered off, washed with chilled ethanol (2 × 5 ml), dried and recrystallized from the proper solvent, to afford the pure products 79 with quantitative yields.

4.3.1. (2Z,2'Z)-3,3'-((1R,4R)-Cyclohexane-1,4-diyl)bis(N-benzyl-4-(2-methoxyphenyl)thiazol-2(3H)-imine) 7a

Brown crystals, yield 98%, m.p. 311–314°C; IR (KBr): ν/cm−1 1615 (C=N, C=C); 1H NMR (400 MHz, CDCl3): δ 7.13–7.04 (m, 18H, Ar-H), 6.87 (s, 2H, triazole-H), 3.81 (s, 6H, OCH3), 3.28–3.26 (m, 2H, Cyclohexane-H), 2.86 (s, 4H, CH2), 1.96–1.95 (m, 4H, Cyclohexane-H), 1.74–1.69 ppm (m, 4H, Cyclohexane-H); 13C NMR (100 MHz, CDCl3): δ 157.6 (Thiazole-C2), 144.9 (Thiazole-C4), 156.7, 138.3, 128.9, 127.6, 126.5, 125.8, 123.7, 122.4, 115.9, 107.4 (Ar-C), 108.3 (Thiazole-C5), 55.6 (OCH3), 52.1 (Cyclohexane-C), 49.7 (CH2) 31.0 ppm (Cyclohexane-C); MS (EI): m/z (%) 673 (M++1, 2.4), 672 (M+, 8.3), 581 (M+−91, 100).

4.3.2. (2Z,2'Z)-3,3'-((1R,4R)-Cyclohexane-1,4-diyl)bis(N-allyl-4-(2-methoxyphenyl)thiazol-2(3H)-imine) 7b

Brown crystals, yield 99%, m.p. 289–292°C; IR (KBr): ν/cm−1 1604, 1598 (C=N, C=C); 1H NMR (400 MHz, DMSO-d6): δ 7.28–7.23 (m, 8H, Ar-H), 6.92 (s, 2H, triazole-H), 5.82–5.73 (m, 2H, –CH2–CH=CH2), 5.11–5.05 (m, 4H, –CH2–CH=CH2), 4.19–4.17 (m, 4H, –CH2–CH=CH2), 3.79 (s, 6H, OCH3), 3.18–3.13 (m, 2H, Cyclohexane-H), 1.95–1.93 (m, 4H, Cyclohexane-H), 1.27–1.21 ppm (m, 4H, Cyclohexane-H); 13C NMR (100 MHz, DMSO-d6): δ 158.2 (Thiazole-C2), 145.7 (Thiazole-C4), 108.4 (Thiazole-C5), 157.5, 128.8, 122.4, 121.7, 114.7, 108.0 (Ar-C), 135.7 (–CH2CH=CH2), 115.9 (–CH2–CH=CH2), 55.5 (OCH3), 52.0 (Cyclohexane-C), 45.8 (–CH2–CH=CH2), 31.0 ppm (Cyclohexane-C); MS (EI): m/z (%) 573 (M++1, 0.7), 572 (M+, 3.9), 531 (M+−41, 100).

4.3.3. (2Z,2'Z)-N,N'-(1,4-Phenylenebis(methylene))bis(3-benzyl-4-(2-methoxyphenyl)thiazol-2(3H)-imine) 8a, (2Z,2'Z)-3,3'-(1,4-Phenylenebis(methylene))bis(N-benzyl-4-(2-methoxyphenyl)thiazol-2(3H)-imine) 9a

The crude reaction mixture comprising both the non-isolable regioisomeric products was purified by column chromatography (92% DCM/MeOH) to afford the mixture of regioisomers 8a and 9a in the ratio of (56 : 44); Rf=0.39. Brown crystals, yield 96%, m.p. 341–343°C; IR (KBr): ν/cm−1 1608, 1593 (C=N, C=C); 1H NMR (400 MHz, DMSO-d6): δ 7.29–7.18 (m, Ar-H), 6.78–6.77 (m, triazole-H), 4.98–4.95 (m, CH2), 4.65–4.61 (m, CH2), 3.76 (d, 2 OCH3); 13C NMR (100 MHz, DMSO-d6): δ 158.0 (Thiazole-C2), 144.3 (Thiazole-C4), 108.0 (Thiazole-C5), 157.9, 138.7, 136.3, 134.8, 128.8, 128.3, 126.4, 125.5, 122.9, 120.3, 114.3, 107.3 (Ar-C), 56.9 (CH2), 55.7, 55.2 (OCH3), 48.4 ppm (CH2); MS (EI): m/z (%) 696 (M++2, 1.3), 695 (M++1, 2.7), 694 (M+, 100).

4.3.4. (2Z,2'Z)-N,N'-(1,4-Phenylenebis(methylene))bis(3-allyl-4-(2-methoxyphenyl)thiazol-2(3H)-imine) 8b, (2Z,2'Z)-3,3'-(1,4-Phenylenebis(methylene))bis(N-allyl-4-(2-methoxyphenyl)thiazol-2(3H)-imine) 9b

The crude reaction mixture comprising both the inseparable regioisomeric products was purified by column chromatography (94% DCM/MeOH) to afford the mixture of regioisomers 8b and 9b in the ratio of (52 : 48); Rf = 0.43. Brown crystals, yield 95%, m.p. 299–302°C decomposes; IR (KBr): ν/cm−1 1613, 1594 (C=N, C=C); 1H NMR (400 MHz, DMSO-d6): δ 7.36–7.24 (m, Ar-H), 6.80 (d, triazole-H), 5.90 (m, –CH2–CH=CH2), 5.17–5.15 (m, –CH2–CH=CH2), 4.94–4.91 (d, 2 CH2), 4.63–4.60 (d, 2 CH2), 4.40–4.37 (m, CH2–CH=CH2), 3.79 (s, 2 OCH3); 13C NMR (100 MHz, DMSO-d6): δ 158.4 (Thiazole-C2), 144.6 (Thiazole-C4), 107.9 (Thiazole-C5), 158.1, 136.1, 134.7, 129.0, 128.7, 123.3, 121.8, 114.6, 107.5 (Ar-C), 135.7 (–CH2CH=CH2), 115.5 (–CH2–CH=CH2), 45.7 (–CH2–CH=CH2), 56.7 (CH2), 55.6, 55.3 (OCH3), 48.7 ppm (CH2); MS (EI): m/z (%) 595 (M++1, 23.6), 594 (M+, 100).

4.4. Synthesis of derivatives 10a–d and 11a–d

A solution of bis-thioureas 3a–d (1.0 mmol), malonic acid (2.2 mmol) in acetyl chloride (6.0 mmol) or oxalyl chloride (2.2 mmol), was sonicated at 40°C for 7 min. The solid product so obtained was filtered, washed with water (3 × 5 ml) then chilled ethanol (2 × 5 ml), and recrystallized from dioxane.

4.4.1. 3,3'-((1R,4R)-Cyclohexane-1,4-diyl)bis(1-benzyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) 10a

Yellow crystals, yield 99%, m.p. 280–281°C; IR (KBr): ν/cm−1 1678, 1663 (C=O), 1350 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.33–7.28 (m, 10H, Ar-H), 4.92 (s, 4H, N–CH2), 3.93 (br, 2H, Cyclohexane-H), 3.64 (s, 4H, CH2), 1.81–1.79 (m, 4H, Cyclohexane-H), 1.56 (m, 4H, Cyclohexane-H); 13C NMR (100 MHz, DMSO-d6): δ 171.8 (C=S), 166.8 (C=O), 166.5 (C=O), 136.0, 134.7, 128.7, 127.5 (Ar-C), 52.6 (Cyclohexane-C), 51.9 (N–CH2) 41.7 (CH2), 31.2 ppm (Cyclohexane-C); MS (EI): m/z (%) 549 (M++1, 8.6), 548 (M+, 100).

4.4.2. 3,3'-((1R,4R)-Cyclohexane-1,4-diyl)bis(1-allyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) 10b

Yellow crystals, yield 97%, m.p. 272–274°C; IR (KBr): ν/cm−1 1685, 1673 (C=O), 1348 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 5.90–5.77 (m, 2H, –CH2–CH=CH2), 5.16–5.04 (m, 4H, –CH2–CH=CH2), 4.03 (br, 4H, –CH2–CH=CH2), 3.91 (br, 2H, Cyclohexane-H), 3.56 (s, 4H, CH2), 1.92–1.90 (m, 4H, Cyclohexane-H), 1.25–1.19 (m, 4H, Cyclohexane-H); 13C NMR (100 MHz, DMSO-d6): δ 171.9 (C=S), 166.7 (C=O), 166.3 (C=O), 135.2 (–CH2CH=CH2), 115.9 (–CH2–CH=CH2), 52.3 (Cyclohexane-C), 46.2 (–CH2–CH=CH2), 41.5 (CH2), 31.0 ppm (Cyclohexane-C); MS (EI): m/z (%) 449 (M++1, 1.3), 448 (M+, 100).

4.4.3. 3,3'-(1,4-Phenylenebis(methylene))bis(1-benzyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) 10c

Yellow crystals, yield 99%, m.p. 309–311°C; IR (KBr): ν/cm−1 1668, 1660 (C=O), 1349 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.35–7.21 (m, 14H, Ar-H), 4.65 (d, 8H, 2 N–CH2), 3.56 ppm (s, 4H, CH2); 13C NMR (100 MHz, DMSO-d6): δ 172.4 (C=S), 165.6 (C=O), 165.4 (C=O), 135.7, 135.2, 128.5, 128.2, 127.5, 126.8 (Ar-C) 51.5, 51.3, 41.1 ppm (CH2); MS (EI): m/z (%) 571 (M++1, 1.3), 570 (M+, 12.6), 479 (M+−91, 100).

4.4.4. 3,3'-(1,4-Phenylenebis(methylene))bis(1-allyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) 10d

Yellow crystals, yield 98%, m.p. 292–293°C; IR (KBr): ν/cm−1 1684, 1675 (C=O), 1390 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.27 (s, 4H, Ar-H), 5.89–5.81 (m, 2H, –CH2–CH=CH2), 5.17–5.05 (m, 4H, –CH2–CH=CH2), 4.64–4.62 (m, 4H, –CH2–CH=CH2), 4.06 (s, 4H, N–CH2), 3.56 ppm (s, 4H, CH2); 13C NMR (100 MHz, DMSO-d6): δ 172.2 (C=S), 165.7 (C=O), 165.4 (C=O), 135.3, 128.1 (Ar-C), 135.0 (–CH2CH=CH2), 115.6 (–CH2–CH=CH2), 51.7 (CH2), 46.4 (–CH2–CH=CH2), 41.0 ppm (CH2); MS (EI): m/z (%) 471 (M++1, 1.2), 470 (M+, 100).

4.4.5. 3,3'-((1R,4R)-Cyclohexane-1,4-diyl)bis(1-benzyl-2-thioxoimidazolidine-4,5-dione) 11a

Yellow crystals, yield 96%, m.p. 282–283°C; IR (KBr): ν/cm−1 1696, 1687 (C=O), 1358 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.35–7.21 (m, 10H, Ar-H), 4.77 (s, 4H, CH2), 3.92 (br, 2H, Cyclohexane-H), 1.95–1.92 (m, 4H, Cyclohexane-H), 1.28–1.21 (m, 4H, Cyclohexane-H); 13C NMR (100 MHz, DMSO-d6): δ 167.9 (C=S), 161.7 (C=O), 160.9 (C=O), 135.5, 128.5, 127.9, 127.0 (Ar–C), 52.5 (Cyclohexane-C), 51.5 (CH2), 30.8 ppm (Cyclohexane-C); MS (EI): m/z (%) 521 (M++1, 6.3), 520 (M+, 9.6), 429 (M+−91, 100).

4.4.6. 3,3'-((1R,4R)-Cyclohexane-1,4-diyl)bis(1-allyl-2-thioxoimidazolidine-4,5-dione) 11b

Yellow crystals, yield 97%, m.p. 277–279°C; IR (KBr): ν/cm−1 1695, 1689 (C=O), 1385 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 5.89–5.81 (m, 2H, –CH2–CH=CH2), 5.17–5.04 (m, 4H, –CH2–CH=CH2), 4.05 (br, 4H, –CH2–CH=CH2), 3.80 (br, 2H, Cyclohexane-H), 1.90 (br, 4H, Cyclohexane-H), 1.22 (br, 4H, Cyclohexane-H); 13C NMR (100 MHz, DMSO-d6): δ 167.7 (C=S), 161.5 (C=O), 160.7 (C=O), 135.3 (–CH2CH=CH2), 115.9 (–CH2–CH=CH2), 46.7 (–CH2–CH=CH2), 51.8 (Cyclohexane-C), 31.3 ppm (Cyclohexane-C); MS (EI): m/z (%) 421 (M++1, 3.0), 420 (M+, 100).

4.4.7. 3,3'-(1,4-Phenylenebis(methylene))bis(1-benzyl-2-thioxoimidazolidine-4,5-dione) 11c

Yellow crystals, yield 93%, m.p. 317–320°C; IR (KBr): ν/cm−1 1705, 1698 (C=O), 1390 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.35–7.21 (m, 14H, Ar-H), 4.66 (s, 4H, CH2), 4.64 (s, 4H, CH2); 13C NMR (100 MHz, DMSO-d6): δ 167.4 (C=S), 161.4 (C=O), 161.1 (C=O), 136.0, 134.9, 128.8, 128.0, 127.1, 126.8 (Ar-C) 51.7, 51.5 ppm (CH2); MS (EI): m/z (%) 543 (M++1, 7.7), 542 (M+, 100).

4.4.8. 3,3'-(1,4-Phenylenebis(methylene))bis(1-allyl-2-thioxoimidazolidine-4,5-dione) 11d

Yellow crystals, yield 96%, m.p. 299–302°C; IR (KBr): ν/cm−1 1711, 1704 (C=O), 1395 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.23 (s, 4H, Ar-H), 5.90–5.80 (m, 2H, –CH2–CH=CH2), 5.18–5.03 (m, 4H, –CH2–CH=CH2), 4.65–4.63 (m, 4H, –CH2–CH=CH2), 4.05 ppm (s, 4H, CH2); 13C NMR (100 MHz, DMSO-d6): δ 166.4 (C=S), 161.3 (C=O), 161.2 (C=O), 135.5 (–CH2CH=CH2), 134.6, 128.0 (Ar-C), 115.8 (–CH2–CH=CH2), 51.9 (CH2), 46.5 ppm (–CH2–CH=CH2); MS (EI): m/z (%) 443 (M++1, 5.9), 442 (M+, 100).

4.5. Synthesis of bis-2,1-benzisoxazole derivatives 13a–d

A mixture of bis-thiobarbituric acids 10a–d (1.0 mmol) and o-nitrobenzaldehyde (2.0 mmol) in water (10 ml) was sonicated at 80°C for 5 min. Then, water was removed under reduced pressure and the remaining residue was suspended in ethanol (10 ml), to which, tin chloride dihydrate (4.0 mmol) and concentrated hydrochloric acid (2 ml) was added. The resulting mixture was then sonicated for 10 min at 80°C. The obtained hot mixture was filtered off. The solid was washed with diethyl ether (2 × 5 ml) and recrystallized form dioxane containing few drops of DMF to afford bis-2,1-benzisoxazoles.

4.5.1. (5Z,5'Z)-3,3'-((1R,4R)-Cyclohexane-1,4-diyl)bis(5-(benzo[c]isoxazol-3(1H)-ylidene)-1-benzyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) 13a

Brown crystals, yield 92%, m.p. 298–301°C decomposes; IR (KBr): ν/cm−1 3220–3053 (br, NH), 1686 (C=O), 1617, 1590 (C=C), 1387 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.89 (d, J = 8.7 Hz, 2H, Ar-H), 7.35–7.23 (m, 14H, Ar-H), 6.77 (d, J = 8.8 Hz, 2H, Ar-H), 4.82 (s, 4H, CH2), 3.93 (br, 2H, Cyclohexane-H), 1.92–1.90 (m, 4H, Cyclohexane-H), 1.25–1.19 (m, 4H, Cyclohexane-H); 13C NMR (100 MHz, DMSO-d6): δ 178.6 (C=S), 167.3 (C3′), 161.9 (C=O), 161.2 (C=O), 156.5, 136.1, 129.0, 128.4, 127.2, 125.6, 123.9, 119.0, 114.5, 113.3 (Ar-C), 86.8 (C5), 52.8 (Cyclohexane-C), 51.0 (CH2), 30.3 ppm (Cyclohexane-C); MS (EI): m/z (%) 783 (M++1, 0.6), 782 (M+, 1.6), 691(M+−91, 100).

4.5.2. (5Z,5'Z)-3,3'-((1R,4R)-Cyclohexane-1,4-diyl)bis(1-allyl-5-(benzo[c]isoxazol-3(1H)-ylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) 13b

Brown crystals, yield 89%, m.p. 287–288°C decomposes; IR (KBr): ν/cm−1 3262–3011 (br, NH), 1677 (C=O), 1619, 1584 (C=C), 1345 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.80 (d, J = .9 Hz, 2H, Ar-H), 7.29–7.18 (m, 4H, Ar-H), 6.77 (d, J = 8.8 Hz, 2H, Ar-H), 5.89–5.80 (m, 2H, –CH2–CH=CH2), 5.17–5.05 (m, 4H, –CH2–CH=CH2), 4.63 (m, 4H, –CH2–CH=CH2), 3.49 (br, 2H, Cyclohexane-H), 1.76–1.74 (m, 4H, Cyclohexane-H), 1.45–1.39 (m, 4H, Cyclohexane-H); 13C NMR (100 MHz, DMSO-d6): δ 178.5 (C=S), 167.9 (C3′), 161.2 (C=O), 160.8 (C=O), 156.8, 130.6, 125.6, 120.0, 114.4, 113.8 (Ar-C), 135.1 (–CH2CH=CH2), 115.6 (–CH2–CH=CH2), 86.2 (C5), 51.9 (Cyclohexane-C), 46.9 (–CH2–CH=CH2), 31.0 ppm (Cyclohexane-C); MS (EI): m/z (%) 683 (M++1, 3.5), 682 (M+, 100).

4.5.3. (5Z,5'Z)-3,3'-(1,4-Phenylenebis(methylene))bis(5-(benzo[c]isoxazol-3(1H)-ylidene)-1-benzyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) 13c

Red crystals, yield 93%, m.p. 311–313°C decomposes; IR (KBr): ν/cm−1 3206–2863 (br, NH), 1669 (C=O), 1625, 1603 (C=C), 1344 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.98 (d, J = 8.7 Hz, 2H, Ar-H), 7.32–7.22 (m, 18H, Ar-H), 6.78 (d, J = 8.7 Hz, 2H, Ar-H), 4.78 (s, 8H, CH2); 13C NMR (100 MHz, DMSO-d6): δ 179.0 (C=S), 166.8 (C3′), 162.0 (C=O), 161.4 (C=O), 155.9, 136.0, 131.3, 128.8, 128.2, 127.6, 127.2, 126.9, 126.2, 119.6, 114.8, 113.2 (Ar-C), 86.2 (C5), 51.9, 51.4 ppm (CH2); MS (EI): m/z (%) 805 (M++1, 1.4), 804 (M+, 100).

4.5.4. (5Z,5'Z)-3,3'-(1,4-Phenylenebis(methylene))bis(1-allyl-5-(benzo[c]isoxazol-3(1H)-ylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) 13d

Yellow crystals, yield 95%, m.p. 297–299°C; IR (KBr): ν/cm−1 3341–3069 (br, NH), 1683 (C=O), 1624, 1598 (C=C), 1369 (C=S); 1H NMR (400 MHz, DMSO-d6): δ 7.89 (br, 2H, Ar-H), 7.35–7.23 (m, 8H, Ar-H), 6.80 (d, J = 8.8 Hz, 2H, Ar-H), 5.89–5.80 (m, 2H, –CH2–CH=CH2), 4.99 (br, 4H, –CH2–CH=CH2), 4.56 (br, 4H, –CH2–CH=CH2), 4.01 ppm (m, 4H, CH2); 13C NMR (100 MHz, DMSO-d6): δ 179.1 (C=S), 167.4 (C3′), 161.5 (C=O), 161.1 (C=O), 155.9, 134.6, 130.7, 128.3, 126.1, 119.5, 114.2, 113.6 (Ar-C), 135.7 (–CH2CH=CH2), 115.9 (–CH2–CH=CH2), 51.7 (CH2), 86.2 (C5), 46.4 ppm (–CH2–CH=CH2); MS (EI): m/z (%) 705 (M++1, 2.8), 704 (M+, 100).

Supplementary Material

Supplementary information
rsos181963supp1.pdf (3MB, pdf)
Reviewer comments

Data accessibility

The datasets supporting this article have been uploaded as part of the electronic supplementary material.

Authors' contributions

W.A.A.A. designed and performed experimental part of the work, managed the research, performed data analysis and wrote the manuscript. H.M.I. assisted with designing, performing experimental part, data analysis, writing and revising of the manuscript.

Competing interests

We have no competing interests.

Funding

This study was financially supported by the Jouf University, project no. 634/39.

References

  • 1.Chirkunov AA, Kuznetsov YI, Shikhaliev KS, Agafonkina MO, Andreev NP, Kazansky LP, Potapov AY. 2018. Adsorption of 5-alkyl-3-amino-1,2,4-triazoles from aqueous solutions and protection of copper from atmospheric corrosion. Corros. Sci. 144, 230–236. ( 10.1016/j.corsci.2018.08.056) [DOI] [Google Scholar]
  • 2.Zhang Y, Zhan Y, Ma Y, Hua XW, Wei W, Zhang X, Song HB, Li ZM, Wang BL. 2018. Synthesis, crystal structure and 3D-QSAR studies of antifungal (bis-)1,2,4-triazole Mannich bases containing furyl and substituted piperazine moieties. Chin. Chem. Lett. 29, 441–446. ( 10.1016/j.cclet.2017.08.035) [DOI] [Google Scholar]
  • 3.El-Sherief HAM, Youssif BGM, Bukharic SNA, Abdelazeem AH, Abdel-Azize M, Abdel-Rahman HM. 2018. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors. Eur. J. Med. Chem. 156, 774–789. ( 10.1016/j.ejmech.2018.07.024) [DOI] [PubMed] [Google Scholar]
  • 4.Clemons M, Coleman RE, Verma S. 2004. Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard? Cancer Treat. Rev. 30, 325–332. ( 10.1016/j.ctrv.2004.03.004) [DOI] [PubMed] [Google Scholar]
  • 5.Shujuan S, Hongxiang L, Gao Y, Fan P, Ba M, Ge W, Wang X. 2004. Liquid chromatography–tandem mass spectrometric method for the analysis of fluconazole and evaluation of the impact of phenolic compounds on the concentration of fluconazole in Candida albicans. J. Pharm. Biomed. Anal. 34, 1117–1124. ( 10.1016/j.jpba.2003.11.013) [DOI] [PubMed] [Google Scholar]
  • 6.Guin S, Rout SK, Khatun N, Ghosh T, Patel BK. 2012. Tandem synthesis of [1,2,4]-triazoles mediated by iodine—a regioselective approach. Tetrahedron 68, 5066–5074. ( 10.1016/j.tet.2012.04.042) [DOI] [Google Scholar]
  • 7.Katritzky AR, Ramsden CA, Scriven EFV, Taylor RJK. 2008. Comprehensive heterocyclic chemistry III. Ed, Vol. 5, pp. 160–209. New York, NY: Elsevier Ltd. [Google Scholar]
  • 8.Zhou CH, Wang Y. 2012. Recent researches in triazole compounds as medicinal drugs. Curr. Med. Chem. 19, 239–280. ( 10.2174/092986712803414213) [DOI] [PubMed] [Google Scholar]
  • 9.Geronikaki A, Argyropoulou I, Vicini P, Zani F. 2009. Synthesis and biological evaluation of sulfonamide thiazole and benzothiazole derivatives as antimicrobial agents. Arkivoc 6, 89–102. ( 10.3998/ark.5550190.0010.611) [DOI] [Google Scholar]
  • 10.Kachroo M, Rao GK, Rajasekaran S, Pai SPN, Hemalatha YR. 2011. Synthesis, antibacterial and antioxidant activity of N-[(4E)-arylidene-5-oxo-2-phenyl-4, 5-dihydro-1H-imidazol-1-yl]-2-(2-methyl-1, 3-thiazol-4-yl) acetamide. Der Pharma Chemica 3, 241–245. [Google Scholar]
  • 11.Kashyap SJ, Sharma PK, Garg VK, Dudhe R, Kumar N. 2011. Review on synthesis and various biological potential of thiazolopyrimidine derivatives. J. Adv. Sci. Res. 2, 18. [Google Scholar]
  • 12.Aoyama T, Murata S, Arai I, Araki N, Takido T, Suzuki Y, Kodomari M. 2006. One pot synthesis using supported reagents system KSCN/SiO2–RNH3OAc/Al2O3: synthesis of 2-aminothiazoles and N-allylthioureas. Tetrahedron 62, 3201–3213. ( 10.1016/j.tet.2006.01.075) [DOI] [Google Scholar]
  • 13.Ayati A, Emami S, Asadipour A, Shafiee A, Foroumadi A. 2015. Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. Eur. J. Med. Chem. 97, 699–718. ( 10.1016/j.ejmech.2015.04.015) [DOI] [PubMed] [Google Scholar]
  • 14.Kidwai M, Thakur R, Mohan R. 2005. Eco-friendly synthesis of novel antifungal (thio)barbituric acid derivatives. Acta Chim. Slov. 52, 88–92. [Google Scholar]
  • 15.Kadoma Y, Fujisawa S. 2012. Radical-scavenging activity of thiols, thiobarbituric acid derivatives and phenolic antioxidants determined using the induction period method for radical polymerization of methyl methacrylate. Polymers 4, 1025–1036. ( 10.3390/polym4021025) [DOI] [Google Scholar]
  • 16.Lee JH, Lee S, Park M, Myung H. 2011. Characterization of thiobarbituric acid derivatives as inhibitors of hepatitis C virus NS5B polymerase. J. Virol. 8, 18 ( 10.1186/1743-422X-8-18) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Faidallah HM, Khan KA. 2012. Synthesis and biological evaluation of new barbituric and thiobarbituric acid fluoro analogs of benzenesulfonamides as antidiabetic and antibacterial agents. J. Fluor. Chem. 142, 96–104. ( 10.1016/j.jfluchem.2012.06.032) [DOI] [Google Scholar]
  • 18.Barakat A, Ali M, Al-Majid AM, Yousuf S, Choudhary MI, Khalil R, Ul-Haq Z. 2017. Synthesis of thiobarbituric acid derivatives: in vitro α-glucosidase inhibition and molecular docking studies. Bioorg. Chem. 75, 99–105. ( 10.1016/j.bioorg.2017.09.003) [DOI] [PubMed] [Google Scholar]
  • 19.Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amina S, Sharma AK. 2018. Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells. Eur. J. Med. Chem. 143, 1919–1930. ( 10.1016/j.ejmech.2017.11.006) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Refat MS, El-Korashy SA, Ahmed AS. 2008. A convenient method for the preparation of barbituric and thiobarbituric acid transition metal complexes. Acta A: Mol. Biomol. Spectrosc. 71, 1084–1094. ( 10.1016/j.saa.2008.03.001) [DOI] [PubMed] [Google Scholar]
  • 21.Kala K, Vineetha PK, Manoj N. 2017. A simple cost effective carbazole–thiobarbituric acid conjugate as a ratiometric fluorescent probe for detection of mercury(II) ions in aqueous medium. New J. Chem. 41, 5176–5181. ( 10.1039/C7NJ00805H) [DOI] [Google Scholar]
  • 22.Masoud MS, El-Kaway MYA, Hindawy AM, Soyaed AA. 2012. Chemical speciation and equilibria of some nucleic acid compounds and their iron(III) complexes. Acta A: Mol. Biomol. Spectrosc. 92, 256–282. ( 10.1016/j.saa.2012.02.066) [DOI] [PubMed] [Google Scholar]
  • 23.Zaki ZM, Mohamed GG. 2000. Spectral and thermal studies of thiobarbituric acid complexes. Acta A: Mol. Biomol. Spectrosc. 56, 1245–1250. ( 10.1016/S1386-1425(99)00225-5) [DOI] [PubMed] [Google Scholar]
  • 24.Yu TC, Sinnhuber RO. 1964. Further observations on the 2-thiobarbituric acid method for the measurement of oxidative rancidity. J. Am. Oil Chem. Soc. 41, 540–543. ( 10.1007/BF02898128) [DOI] [Google Scholar]
  • 25.Yamauchi K, Nagai Y, Ohashi T. 1982. Quantitative relationship between alpha-tocopherol and polyunsaturated fatty acids and its connection to development of oxidative rancidity in chicken skeletal muscle. Agric. Biol. Chem. 46, 2719–2724. ( 10.1271/bbb1961.46.2719) [DOI] [Google Scholar]
  • 26.Sidewell CG, Salwin H, Mitchell JH. 1955. Measurement of oxidation in dried milk products with thiobarbituric acid. J. Am. Oil Chem. Soc. 32, 13–16. ( 10.1007/BF02636471) [DOI] [Google Scholar]
  • 27.Mohamed NA, Yassin AA, Sabaa KMW. 2000. Organic thermal stabilizers for rigid poly(vinyl chloride) I. Barbituric and thiobarbituric acids. Polym. Degrad. Stab. 70, 5–10. ( 10.1016/S0141-3910(00)00054-9) [DOI] [Google Scholar]
  • 28.Flick AC, Ding HX, Leverett CA, Kyne RE, Liu KKC, Fink SJ, O'Donnell CJ. 2017. Synthetic approaches to the new drugs approved during 2015. J. Med. Chem. 60, 6480–6515. ( 10.1021/acs.jmedchem.7b00010) [DOI] [PubMed] [Google Scholar]
  • 29.Nagle AS, et al. 2014. Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem. Rev. 114, 11 305–11 347. ( 10.1021/cr500365f) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Li M, et al. 2017. Synthesis and evaluation of diphenyl conjugated imidazole derivatives as potential glutaminyl cyclase inhibitors for treatment of Alzheimer's disease. J. Med. Chem. 60, 6664–6677. ( 10.1021/acs.jmedchem.7b00648) [DOI] [PubMed] [Google Scholar]
  • 31.Revuelta J, Machetti F, Cicchi S. 2011. Modern heterocyclic chemistry, vol. 2, pp. 809–923. Weinheim, Germany: Wiley-VCH. [Google Scholar]
  • 32.Herrmann WA. 2002. N-heterocyclic carbenes: a new concept in organometallic catalysis. Angew. Chem. Int. Ed. 41, 1290–1309. () [DOI] [PubMed] [Google Scholar]
  • 33.Boiani M, Gonzalez M. 2005. Imidazole and benzimidazole derivatives as chemotherapeutic agents. Mini-Rev. Med. Chem. 5, 409–424. ( 10.2174/1389557053544047) [DOI] [PubMed] [Google Scholar]
  • 34.Divya V, Vikash S, Singh OG, Shubha J. 2017. Ultrasound-assisted high-yield multicomponent synthesis of triazolo[1,2-a]indazole-triones using silica-coated ZnO nanoparticles as a heterogeneous catalyst. Green Chem. 19, 5885–5899. ( 10.1039/C7GC03279J) [DOI] [Google Scholar]
  • 35.Yasui K, Tuziuti T, Kanematsu W. 2018. Mysteries of bulk nanobubbles (ultrafine bubbles); stability and radical formation. Ultrason. Sonochem. 48, 259–266. ( 10.1016/j.ultsonch.2018.05.038) [DOI] [PubMed] [Google Scholar]
  • 36.Arafa WAA, Shaker RM. 2016. A facile green chemistry approaches towards the synthesis of bis-Schiff bases using ultrasound versus microwave and conventional method without catalyst. Arkivoc 3, 187 ( 10.3998/ark.5550190.p009.464) [DOI] [Google Scholar]
  • 37.Arafa WAA, Abdel-Magied AF. 2017. Utilization of ultrasonic irradiation as green and effective one-pot protocol to prepare a novel series of bis-2-amino-1,3,4-oxa(thia)diazoles and bis-tetrazoles. Arkivoc 5, 327–340. ( 10.24820/ark.5550190.p010.197) [DOI] [Google Scholar]
  • 38.Arafa WAA. 2018. An eco-compatible pathway to the synthesis of mono and bis-multisubstituted imidazoles over novel reusable ionic liquids: an efficient and green sonochemical process. RSC Adv. 8, 16 392–16 399. ( 10.1039/C8RA02755B) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Arafa WAA, Ibrahim HM. 2018. A sustainable strategy for the synthesis of bis-2-iminothiazolidin-4-ones utilizing novel series of asymmetrically substituted bis-thioureas as viable precursors. RSC Adv. 8, 10 516–10 521. ( 10.1039/C8RA01253A) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Arafa WAA, Faty RAM, Mourad AK. 2018. A new sustainable strategy for synthesis of novel series of bis-imidazole and bis-1,3-thiazine derivatives. J. Heterocycl. Chem. 55, 1886–1894. ( 10.1002/jhet.3221) [DOI] [Google Scholar]
  • 41.Arafa WAA. 2019. Deep eutectic solvent for an expeditious sono-synthesis of novel series of bis-quinazolin-4-one derivatives as potential anti-cancer agents. R. Soc. open sci. 6, 182046 ( 10.1098/rsos.182046) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Leonardi M, Villacampa M, Menendez JC. 2018. Multicomponent mechanochemical synthesis. Chem. Sci. 9, 2042–2064. ( 10.1039/C7SC05370C) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Sysak A, Mrukowicz BO. 2017. Isoxazole ring as a useful scaffold in a search for new therapeutic agents. Eur. J. Med. Chem. 137, 292–309. ( 10.1016/j.ejmech.2017.06.002) [DOI] [PubMed] [Google Scholar]
  • 44.Serrano JL, Cavalheiro E, Barroso S, Romão MJ, Silvestrea S, Almeida P. 2017. A synthetic route to novel 3-substituted-2,1-benzisoxazoles from 5-(2-nitrobenzylidene)(thio)barbiturates. C. R. Chim. 20, 990–995. ( 10.1016/j.crci.2017.10.002) [DOI] [Google Scholar]
  • 45.Mason TJ, Lorimer JP. 2002. Applied sonochemistry: the use of power ultrasound in chemistry and processing, 1st edn Weinham, Germany: Wiley-VCH Verlag GmbH. [Google Scholar]
  • 46.Xu H, Zeiger BW, Suslick KS. 2013. Sonochemical synthesis of nanomaterials. Chem. Soc. Rev. 42, 2555–2567. ( 10.1039/C2CS35282F) [DOI] [PubMed] [Google Scholar]
  • 47.Shahrnoy AA, Mahjoub AR, Morsali A, Dusek M, Eigner V. 2018. Sonochemical synthesis of polyoxometalate based of ionic crystal nanostructure: a photocatalyst for degradation of 2,4-dichlorophenol. Ultrason. Sonochem. 40, 174–183. ( 10.1016/j.ultsonch.2017.07.018) [DOI] [PubMed] [Google Scholar]
  • 48.Gonzalez CJ, Constable DJC, Ponder CS. 2012. Evaluating the ‘Greenness’ of chemical processes and products in the pharmaceutical industry—a green metrics primer. Chem. Soc. Rev. 41, 1485–1498. ( 10.1039/C1CS15215G) [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary information
rsos181963supp1.pdf (3MB, pdf)
Reviewer comments

Data Availability Statement

The datasets supporting this article have been uploaded as part of the electronic supplementary material.


Articles from Royal Society Open Science are provided here courtesy of The Royal Society

RESOURCES